Adding Immune-based Treatments to Standard Glioblastoma Therapy

Adding Immune-based Treatments to Standard Glioblastoma Therapy

This clinical trial is testing standard therapy (surgery, radiation and temozolomide) plus immunotherapy with pembrolizumab with or without a cancer treatment vaccine for patients with newly diagnosed glioblastoma, a common and deadly type of brain tumor.



from Cancer Information - Adding Immune-based Treatments to Standard Glioblastoma Therapy

0 коммент.